Skip to main content
Clinical Trials/CTRI/2023/05/052753
CTRI/2023/05/052753
Not yet recruiting
未知

Comparative study of efficacy and adverse effect profile of treatment with methotrexate (0.3 mg/kg/week) versus a combination of low dose of methotrexate (0.15 mg/kg/week) plus low dose of acitretin (0.3 mg/kg/day) in chronic plaque psoriasis

Department of Dermatology and Venereology0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Dermatology and Venereology
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Dermatology and Venereology

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of age 18\-65 years
  • 2\. Given their consent to participate in the study
  • 3\. BSA \>10, PASI \>10
  • 4\. Cumulative methotrexate dose \< 1\.5 gm
  • 5\. Not taking any systemic therapy for 1 month prior to enrolment
  • 6\. Not applying topical therapy for 2 weeks prior to enrolment

Exclusion Criteria

  • 1\. Pregnancy or lactation
  • 2\. History of alcoholism
  • 3\. Taking hepatotoxic or nephrotoxic drugs
  • 4\. History of prior treatment with oral retinoids
  • 5\. Hemoglobin \< 8 gm/ dL
  • 6\. TLC \< 4000 cells/mm3
  • 7\. Platelet count \< 1 lakh/mm3
  • 8\. Lymphocytes \< 1500/mm3
  • 9\. Raised SGPT/OT \>\= twice the normal limit at baseline or \>\= thrice the normal limit at follow up
  • 10\. Raised total bilirubin \> 1\.2 or 30 % increase in baseline

Outcomes

Primary Outcomes

Not specified

Similar Trials